NO20052306L - Dispergerbare farmasoytiske blandinger. - Google Patents
Dispergerbare farmasoytiske blandinger.Info
- Publication number
- NO20052306L NO20052306L NO20052306A NO20052306A NO20052306L NO 20052306 L NO20052306 L NO 20052306L NO 20052306 A NO20052306 A NO 20052306A NO 20052306 A NO20052306 A NO 20052306A NO 20052306 L NO20052306 L NO 20052306L
- Authority
- NO
- Norway
- Prior art keywords
- prevention
- vehicle
- treatment
- pharmaceutical compositions
- administration
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 208000005141 Otitis Diseases 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000008365 aqueous carrier Substances 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000019258 ear infection Diseases 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 210000005075 mammary gland Anatomy 0.000 abstract 1
- 208000004396 mastitis Diseases 0.000 abstract 1
- 235000019808 microcrystalline wax Nutrition 0.000 abstract 1
- 239000004200 microcrystalline wax Substances 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43498502P | 2002-12-19 | 2002-12-19 | |
| US10/687,986 US7842791B2 (en) | 2002-12-19 | 2003-10-17 | Dispersible pharmaceutical compositions |
| PCT/US2003/039508 WO2004060345A2 (en) | 2002-12-19 | 2003-12-11 | Dispersible pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052306D0 NO20052306D0 (no) | 2005-05-11 |
| NO20052306L true NO20052306L (no) | 2005-07-19 |
Family
ID=32717791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052306A NO20052306L (no) | 2002-12-19 | 2005-05-11 | Dispergerbare farmasoytiske blandinger. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7842791B2 (de) |
| EP (1) | EP1575618B1 (de) |
| JP (1) | JP3803683B2 (de) |
| KR (1) | KR100752836B1 (de) |
| CN (1) | CN100355457C (de) |
| AR (1) | AR042537A1 (de) |
| AT (1) | ATE336264T1 (de) |
| AU (1) | AU2003296947B2 (de) |
| BR (1) | BR0317104B1 (de) |
| CA (1) | CA2504065C (de) |
| CY (1) | CY1105202T1 (de) |
| DE (1) | DE60307677T2 (de) |
| DK (1) | DK1575618T3 (de) |
| ES (1) | ES2268496T3 (de) |
| HK (1) | HK1081457A1 (de) |
| MX (1) | MXPA05006739A (de) |
| NO (1) | NO20052306L (de) |
| NZ (1) | NZ540715A (de) |
| PL (1) | PL377518A1 (de) |
| PT (1) | PT1575618E (de) |
| RU (1) | RU2311201C2 (de) |
| SI (1) | SI1575618T1 (de) |
| TW (1) | TW200420299A (de) |
| WO (1) | WO2004060345A2 (de) |
| ZA (1) | ZA200504873B (de) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| MXPA05004278A (es) | 2002-10-25 | 2005-10-05 | Foamix Ltd | Espuma cosmetica y farmaceutica. |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| US20050004098A1 (en) * | 2003-03-20 | 2005-01-06 | Britten Nancy Jean | Dispersible formulation of an anti-inflammatory agent |
| US20050009931A1 (en) * | 2003-03-20 | 2005-01-13 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| EP1651210A1 (de) * | 2003-07-31 | 2006-05-03 | Pharmacia & Upjohn Company LLC | Dispergierbare formulierung eines entzündungshemmenden wirkstoffs |
| US20060046970A1 (en) * | 2004-08-31 | 2006-03-02 | Insite Vision Incorporated | Topical otic compositions and methods of topical treatment of prevention of otic infections |
| WO2006077856A1 (ja) * | 2005-01-19 | 2006-07-27 | Nippon Zenyaku Kogyo Co., Ltd. | 乳房炎用注入剤 |
| KR100748252B1 (ko) | 2006-05-08 | 2007-08-10 | 주식회사 삼양애니팜 | 플로르페니콜 및 타이로신 함유 주사용 조성물 |
| WO2008025773A1 (en) * | 2006-08-30 | 2008-03-06 | Intervet International B.V. | Pharmaceutical compositions comprising cefquinome |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| WO2008096918A1 (en) * | 2007-02-09 | 2008-08-14 | Kolon Industries, Inc | Reactive antibioties and a method of preparing the same and antibacterial fiber treated thereby |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| AU2009271129B2 (en) * | 2008-07-14 | 2013-10-10 | Otonomy, Inc. | Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| BR112012007473A2 (pt) | 2009-10-02 | 2019-05-07 | Foamix Ltd | composições tópicas de tetraciclina e respectivo método de uso |
| CN101804058A (zh) * | 2010-04-22 | 2010-08-18 | 中国农业科学院兰州畜牧与兽药研究所 | 一种用于防治奶牛干奶期乳房炎的药物及制备方法 |
| SG10201508982TA (en) * | 2010-11-01 | 2015-12-30 | Melinta Therapeutics Inc | Pharmaceutical compositions |
| CN102058612B (zh) * | 2011-01-06 | 2012-07-04 | 河南亚卫动物药业有限公司 | 一种兽用复方乳浊液及其制备方法 |
| US9730913B2 (en) * | 2011-10-13 | 2017-08-15 | The Johns Hopkins University | High affinity beta lactamase inhibitors |
| KR101352867B1 (ko) | 2011-11-07 | 2014-01-21 | 주식회사 한동 | 동물용 복합항생제 조성물 |
| ES2740958T3 (es) | 2012-02-27 | 2020-02-07 | Bayer New Zealand Ltd | Composiciones de liberación controlada y sus procedimientos de uso |
| CN103479660A (zh) * | 2012-06-14 | 2014-01-01 | 符波 | 一种治疗奶牛临床型乳房炎的乳房注入剂及其制备方法 |
| KR101458611B1 (ko) * | 2012-08-02 | 2014-11-11 | 주식회사 한동 | 동물용 복합항생제 조성물 |
| EP2953624B1 (de) * | 2013-02-08 | 2019-08-21 | Luoda Pharma Limited | Verfahren zur behandlung von mikrobiellen infektionen, einschliesslich mastitis |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| CN106265595B (zh) * | 2016-09-29 | 2019-05-03 | 甘肃瑞和祥生物科技有限公司 | 一种肠溶吉他霉素缓释微球及其制备方法 |
| CN106361707B (zh) * | 2016-09-30 | 2019-02-26 | 广东温氏大华农生物科技有限公司 | 一种酒石酸泰万菌素颗粒制剂及其制备方法 |
| CN109045044B (zh) * | 2018-07-04 | 2020-11-17 | 佛山市南海东方澳龙制药有限公司 | 一种复方药剂及其制备方法、用途 |
| US20220125798A1 (en) * | 2019-03-06 | 2022-04-28 | Zoetis Services Llc | Ready-to-use injectable formulations |
| CN112716898A (zh) * | 2021-02-22 | 2021-04-30 | 青岛康地恩动物药业有限公司 | 一种替米考星自乳化口服制剂及其制备方法 |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA670254A (en) | 1963-09-10 | E. Gouge Hardin | Mastitis composition | |
| US3144386A (en) | 1958-05-09 | 1964-08-11 | Merck & Co Inc | Mastitis aerosol foam |
| GB980282A (en) | 1960-03-24 | 1965-01-13 | Philips Roxane | Antibiotic mastitis composition |
| US3135658A (en) | 1961-10-10 | 1964-06-02 | Merck & Co Inc | Non-aqueous oleaginous aerosol foam therapy of bovine mastitis |
| US3347743A (en) | 1964-01-03 | 1967-10-17 | Richardson Merrell Inc | Method of treating bovine masititis |
| GB1089523A (en) | 1964-06-25 | 1967-11-01 | Astra Hewlett Ltd | Improvements in or relating to veterinary compositions for treating mastitis |
| GB1181527A (en) | 1966-09-21 | 1970-02-18 | Douglas Gabriel Parizeau | Composition and Method for Treating Mastitis with Therapeutic Agents. |
| US3531481A (en) | 1969-04-21 | 1970-09-29 | Lilly Co Eli | Method for manufacture of crystalline cephalosporin |
| US3636194A (en) | 1969-10-23 | 1972-01-18 | Douglas G Parizeau | Composition and method for treating mastitis with therapeutic agents |
| DE2063896A1 (de) | 1970-12-28 | 1972-07-20 | Dynamit Nobel Ag, 5210 Troisdorf | Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung |
| CA1052697A (en) | 1974-03-29 | 1979-04-17 | Upjohn Company (The) | Composition for treating mastitis in animals |
| DK154939C (da) | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
| US4006138A (en) | 1975-04-11 | 1977-02-01 | Eli Lilly And Company | Crystalline form of sodium O-formylcefamandole |
| US4011312A (en) | 1975-06-25 | 1977-03-08 | American Home Products Corporation | Prolonged release drug form for the treatment of bovine mastitis |
| GB1547164A (en) | 1975-08-14 | 1979-06-06 | Beecham Group Ltd | Veterinary compositions |
| GB1589917A (en) | 1976-11-27 | 1981-05-20 | Beecham Group Ltd | Pharmaceutical composition containing a clavulanic acid derivative |
| DE2760123C2 (de) | 1976-01-23 | 1986-04-30 | Roussel-Uclaf, Paris | 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
| GB1532682A (en) | 1976-04-27 | 1978-11-22 | Bristol Myers Co | Process for the preparation of cephadroxil |
| US4172138A (en) | 1977-03-23 | 1979-10-23 | Rhodes Russell E | Method and composition of matter for the treatment of dry cows for mastitis |
| US4104470A (en) | 1977-06-03 | 1978-08-01 | Eli Lilly And Company | Crystallization process for cefazolin sodium |
| IT1162442B (it) | 1978-01-17 | 1987-04-01 | Glaxo Group Ltd | Procedimento per preparare il sale sodico di cefurossima in forma cristallina |
| DE2907460A1 (de) | 1978-03-07 | 1979-09-13 | Sandoz Ag | Neue resorbierbare galenische kompositionen |
| US4299501A (en) * | 1979-08-10 | 1981-11-10 | Ortho Pharmaceutical Corporation | Continuous process for the preparation of semisolid dispersions |
| FR2479229B1 (fr) | 1980-03-26 | 1986-01-17 | Clin Midy | Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives |
| NL8002636A (nl) | 1980-05-08 | 1981-12-01 | Gist Brocades Nv | Solvaat van amoxicilline, werkwijze ter bereiding hiervan en werkwijze ter bereiding van injectiepreparaten uit dit solvaat. |
| EP0058015A3 (de) | 1981-02-05 | 1982-08-25 | Beecham Group Plc | Infektionsbehandlung |
| JPS57134482A (en) | 1981-02-13 | 1982-08-19 | Dainippon Pharmaceut Co Ltd | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation |
| US4400503A (en) | 1981-10-30 | 1983-08-23 | Eli Lilly And Company | Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid |
| JPS58198489A (ja) | 1982-05-14 | 1983-11-18 | Meiji Seika Kaisha Ltd | ７β−（２Ｄ−２−アミノ−２−カルボキシエチルチオアセトアミド）−７α−メトキシ−３−（１−メチル−１Ｈ−テトラゾ−ル−５−イル）−チオメチル−３−セフエム−４−カルボン酸ナトリウム塩の七水和物及びその製造方法 |
| YU44680B (en) | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| US4474780A (en) | 1983-07-22 | 1984-10-02 | Eli Lilly And Company | Crystalline cephalosporin |
| DE3313818A1 (de) | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
| JPS60120886A (ja) | 1983-12-02 | 1985-06-28 | Takeda Chem Ind Ltd | セフェムカルボン酸のナトリウム塩の結晶 |
| US4616080A (en) | 1984-07-02 | 1986-10-07 | Eli Lilly And Company | Simplified process of forming crystalline ceftazidime pentahydrate |
| EP0365044A3 (de) * | 1984-08-02 | 1990-08-22 | Sandoz Ag | Pharmazeutische Verwendung von (NVA)2-Cyclosporin |
| US4902683A (en) * | 1984-10-25 | 1990-02-20 | The Upjohn Company | Crystalline cephalosporin hydrohalide salts |
| EP0233255B1 (de) | 1985-08-12 | 1996-05-29 | The Upjohn Company | Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz |
| IT1190445B (it) | 1985-11-08 | 1988-02-16 | Fatro Spa | Composizioni veterinarie a base di agenti antimicrobici e loro impiego |
| HU194493B (en) | 1985-11-27 | 1988-02-29 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing primycin-containing colloidal basic gel and compositions comprising the same |
| GB8531609D0 (en) | 1985-12-23 | 1986-02-05 | Beecham Group Plc | Compounds |
| US5017380A (en) | 1986-07-02 | 1991-05-21 | Shionogi & Co., Ltd. | Gelatin hard capsule containing crystalline hydrate of oral cephalosporin |
| NZ220764A (en) | 1986-07-02 | 1989-09-27 | Shionogi & Co | Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions |
| CH668187A5 (de) * | 1986-08-07 | 1988-12-15 | Ciba Geigy Ag | Therapeutisches system mit systemischer wirkung. |
| GB8621484D0 (en) | 1986-09-05 | 1986-10-15 | Norbrook Lab Ltd | Intramammary infusion |
| US4723112A (en) | 1986-09-19 | 1988-02-02 | Tektronix, Inc. | Level shift circuit for differential signals |
| GB8629481D0 (en) | 1986-12-10 | 1987-01-21 | Beecham Group Plc | Veterinary treatment |
| IT1214587B (it) | 1986-12-23 | 1990-01-18 | Giovanni Bonfanti | Metodo per la produzione diprodotti cristallini puri. |
| ES2032543T3 (es) | 1987-02-02 | 1993-02-16 | Eli Lilly And Company | Procedimiento mejorado de preparacion de un antibiotico. |
| EP0386000B1 (de) | 1987-07-29 | 1992-03-11 | The Upjohn Company | Kontrollierte freisetzung von antibiotika-salzen aus einem implantat |
| US4898938A (en) | 1987-08-03 | 1990-02-06 | Rifar S.R.L. | Method for preparing crystalline cefadroxil monohydrate |
| US4877782A (en) | 1988-02-16 | 1989-10-31 | The Upjohn Company | Zinc ceftiofur complexes |
| FR2635463A1 (fr) | 1988-08-19 | 1990-02-23 | Veprol | Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glyceride gelifie par au moins un polymere cellulosique |
| KR900004323A (ko) * | 1988-09-29 | 1990-04-12 | 후쿠하라 요시하루 | 유화 조성물 |
| DE3919259A1 (de) | 1989-06-13 | 1990-12-20 | Hoechst Ag | Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung |
| US5143137A (en) | 1990-03-08 | 1992-09-01 | Rite-Hite Corporation | Overlapping seal for insulated folding door |
| US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
| US5342612A (en) | 1991-12-20 | 1994-08-30 | American Cyanamid Company | Compositions for the treatment of mammalian diseases |
| US5314685A (en) | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
| ES2079994B1 (es) | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
| DK0673239T3 (da) | 1992-12-08 | 1999-03-22 | Bimeda Res Dev Ltd | Vandig antibiotisk sammensætning til veterinær anvendelse |
| WO1995031180A1 (en) | 1992-12-08 | 1995-11-23 | Bimeda Research And Development Limited | A veterinary composition |
| SK283674B6 (sk) | 1993-03-12 | 2003-11-04 | Pharmacia & Upjohn Company | Kryštalická voľná kyselina ceftiofuru a spôsob jej prípravy a farmaceutická kompozícia, ktorá ju obsahuje |
| NZ533467A (en) | 1993-07-19 | 2006-02-24 | Angiotech Pharm Inc | Anti-angiogenic compositions and methods of use |
| US6054136A (en) | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
| DE4340781C3 (de) | 1993-11-30 | 2000-01-27 | Novartis Ag | Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung |
| US5635159A (en) | 1994-08-26 | 1997-06-03 | Abbott Laboratories | Aerosol drug formulations containing polyglycolyzed glycerides |
| PT782448E (pt) | 1995-06-06 | 2002-07-31 | Bayer Ag | Formulacoes oticas antibacterianas nao ototoxicas nao sensibilizantes nao irritantes |
| US5736151A (en) * | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
| JP2002513750A (ja) | 1998-05-07 | 2002-05-14 | エラン コーポレーシヨン ピーエルシー | 溶媒／助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム |
| AR018376A1 (es) | 1998-05-26 | 2001-11-14 | Novartis Ag | Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento |
| ATE262916T1 (de) | 1998-08-18 | 2004-04-15 | Panacea Biotec Ltd | Zusammensetzung enthalten cyclsoporin in einem hydrophilen träger |
| US6440964B1 (en) | 1998-09-30 | 2002-08-27 | Alcon Manufacturing, Ltd. | Compositions and methods for treating ophthalmic and otic infections |
| AR020660A1 (es) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Composiciones antibioticas para el tratamiento de ojos, oidos y nariz |
| US6395746B1 (en) | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
| US6509327B1 (en) | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
| IT1303793B1 (it) | 1998-11-27 | 2001-02-23 | Promefarm S R L | "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)" |
| GB9903547D0 (en) * | 1999-02-16 | 1999-04-07 | Novartis Ag | Organic compounds |
| GB9922710D0 (en) * | 1999-09-24 | 1999-11-24 | Bayer Ag | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis |
| US20010049366A1 (en) | 2000-02-09 | 2001-12-06 | Alcon Universal Ltd. | Topical solution formulations containing an antibiotic and a corticosteroid |
| AU2001261748A1 (en) | 2000-05-19 | 2001-12-03 | Alcon Laboratories Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
| PT1317256E (pt) * | 2000-09-12 | 2008-12-17 | Pharmacia & Upjohn Co Llc | Composição farmacêutica com veículo modificado |
-
2003
- 2003-10-17 US US10/687,986 patent/US7842791B2/en active Active
- 2003-12-11 JP JP2004565402A patent/JP3803683B2/ja not_active Expired - Lifetime
- 2003-12-11 AT AT03814728T patent/ATE336264T1/de not_active IP Right Cessation
- 2003-12-11 CN CNB2003801048633A patent/CN100355457C/zh not_active Expired - Lifetime
- 2003-12-11 AU AU2003296947A patent/AU2003296947B2/en not_active Ceased
- 2003-12-11 MX MXPA05006739A patent/MXPA05006739A/es active IP Right Grant
- 2003-12-11 DK DK03814728T patent/DK1575618T3/da active
- 2003-12-11 PL PL377518A patent/PL377518A1/pl not_active Application Discontinuation
- 2003-12-11 DE DE60307677T patent/DE60307677T2/de not_active Expired - Lifetime
- 2003-12-11 PT PT03814728T patent/PT1575618E/pt unknown
- 2003-12-11 RU RU2005119159/15A patent/RU2311201C2/ru not_active IP Right Cessation
- 2003-12-11 SI SI200330409T patent/SI1575618T1/sl unknown
- 2003-12-11 ES ES03814728T patent/ES2268496T3/es not_active Expired - Lifetime
- 2003-12-11 BR BRPI0317104A patent/BR0317104B1/pt active IP Right Grant
- 2003-12-11 KR KR1020057011386A patent/KR100752836B1/ko not_active IP Right Cessation
- 2003-12-11 CA CA2504065A patent/CA2504065C/en not_active Expired - Lifetime
- 2003-12-11 EP EP03814728A patent/EP1575618B1/de not_active Expired - Lifetime
- 2003-12-11 WO PCT/US2003/039508 patent/WO2004060345A2/en active IP Right Grant
- 2003-12-11 NZ NZ540715A patent/NZ540715A/en unknown
- 2003-12-18 TW TW092135958A patent/TW200420299A/zh unknown
- 2003-12-18 AR ARP030104717A patent/AR042537A1/es not_active Application Discontinuation
-
2005
- 2005-05-11 NO NO20052306A patent/NO20052306L/no not_active Application Discontinuation
- 2005-06-14 ZA ZA200504873A patent/ZA200504873B/en unknown
-
2006
- 2006-02-15 HK HK06101908A patent/HK1081457A1/xx not_active IP Right Cessation
- 2006-09-12 CY CY20061101293T patent/CY1105202T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052306L (no) | Dispergerbare farmasoytiske blandinger. | |
| NO20054777L (no) | Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelser | |
| NO20054260L (no) | Disepergebar formulering av en anti-inflammatorisk forbindelse | |
| SG166115A1 (en) | Pharmaceutical preparation containing meloxicam | |
| EA200800798A1 (ru) | Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха | |
| BR0114799A (pt) | Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos | |
| NO20056223L (no) | Preparat til behandling av infeksjon hos kveg og svin | |
| BR0211119A (pt) | Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto | |
| CN108024563A (zh) | 提高家畜中重量增加的生物膜抑制组合物 | |
| ES2082723B1 (es) | Formulacion farmaceutica de fluoxetina en forma dispersable. | |
| NZ597710A (en) | Meso-sized capsules useful for the delivery of agricultural chemicals | |
| CO5650245A2 (es) | Formulaciones dispersable de un agente anti-inflamatorio | |
| EA200970626A1 (ru) | Пестицидная композиция, содержащая фенамидон и инсектицидное соединение | |
| NO20055144L (no) | Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr. | |
| AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| NO20071354L (no) | anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme. | |
| WO2007148919A8 (en) | Bacteriophage having killing activity specific to staphylococcus aureus | |
| MX2020011873A (es) | Nuevos derivados de quinolina. | |
| WO2008116890A3 (en) | Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders | |
| WO2005074986A3 (en) | Bioactive species capable of interfering with a microbial toxin-antitoxin complex and methods for evaluation and use of said bioactive species | |
| MA53927B1 (fr) | Composition pharmaceutique pour une administration par voie orale comprenant un dérivé d'aminopyrimidine ou son sel | |
| MX2021003002A (es) | Composicion para el tratamiento de enfermedades fibroticas, que comprende un compuesto de tioacetamida de benzhidrilo como ingrediente activo. | |
| MX2022003218A (es) | Vacunas para abejas y metodos de uso. | |
| EP2138171A1 (de) | Veterinärmedizinische Zusammensetzung enthaltend Terpinen-4-ol zur Behandlung und Vorbeugung von Mastitis | |
| WO2006012146A3 (en) | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |